Keros Therapeutics, Inc. (KROS)

Keros Therapeutics Statistics

Total Valuation

KROS has a market cap or net worth of $2.17 billion. The enterprise value is $1.66 billion.

Market Cap	2.17B
Enterprise Value	1.66B

Important Dates

The last earnings date was Wednesday, November 6, 2024, after market close.

Earnings Date	Nov 6, 2024
Ex-Dividend Date	n/a

Share Statistics

KROS has 40.51 million shares outstanding. The number of shares has increased by 21.32% in one year.

Current Share Class	40.51M
Shares Outstanding	40.51M
Shares Change (YoY)	+21.32%
Shares Change (QoQ)	+4.12%
Owned by Insiders (%)	0.86%
Owned by Institutions (%)	87.80%
Float	35.37M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.95
P/TBV Ratio	4.08
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2,550.86
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 19.03, with a Debt / Equity ratio of 0.04.

Current Ratio	19.03
Quick Ratio	18.36
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -43.82% and return on invested capital (ROIC) is -29.58%.

Return on Equity (ROE)	-43.82%
Return on Assets (ROA)	-28.17%
Return on Capital (ROIC)	-29.58%
Revenue Per Employee	$4,787
Profits Per Employee	-$1.34M
Employee Count	136
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +77.08% in the last 52 weeks. The beta is 1.24, so KROS's price volatility has been higher than the market average.

Beta (5Y)	1.24
52-Week Price Change	+77.08%
50-Day Moving Average	59.39
200-Day Moving Average	55.42
Relative Strength Index (RSI)	33.99
Average Volume (20 Days)	413,145

Short Selling Information

The latest short interest is 2.41 million, so 5.95% of the outstanding shares have been sold short.

Short Interest	2.41M
Short Previous Month	2.72M
Short % of Shares Out	5.95%
Short % of Float	6.82%
Short Ratio (days to cover)	7.80

Income Statement

In the last 12 months, KROS had revenue of $651,000 and -$181.57 million in losses. Loss per share was -$5.21.

Revenue	651,000
Gross Profit	-164.84M
Operating Income	-204.03M
Pretax Income	-168.05M
Net Income	-181.57M
EBITDA	-202.89M
EBIT	-204.03M
Loss Per Share	-$5.21

Balance Sheet

The company has $530.68 million in cash and $19.29 million in debt, giving a net cash position of $511.40 million or $12.62 per share.

Cash & Cash Equivalents	530.68M
Total Debt	19.29M
Net Cash	511.40M
Net Cash Per Share	$12.62
Equity (Book Value)	532.84M
Book Value Per Share	13.57
Working Capital	523.04M

Cash Flow

In the last 12 months, operating cash flow was -$140.32 million and capital expenditures -$2.18 million, giving a free cash flow of -$142.50 million.

Operating Cash Flow	-140.32M
Capital Expenditures	-2.18M
Free Cash Flow	-142.50M
FCF Per Share	-$3.52

Margins

Gross Margin	n/a
Operating Margin	-31,341.63%
Pretax Margin	-27,890.94%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-53,929.52%

Dividends & Yields

KROS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.32%
Shareholder Yield	-21.32%
Earnings Yield	-8.36%
FCF Yield	-6.56%

Analyst Forecast

The average price target for KROS is $91.43, which is 70.52% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$91.43
Price Target Difference	70.52%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	389.15%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KROS has an Altman Z-Score of 20.45 and a Piotroski F-Score of 4.

Altman Z-Score	20.45
Piotroski F-Score	4